Svp. Jones, MODULATION OF THE INWARDLY RECTIFYING POTASSIUM CHANNEL IRK1 BY THE M1 MUSCARINIC RECEPTOR, Molecular pharmacology, 49(4), 1996, pp. 662-667
Modulation of the inwardly rectifying potassium channel (IRK1) by the
mi muscarinic receptor was studied with the whole-cell patch-clamp rec
ording technique with the use of a mammalian expression system. After
transfection with IRK1 and mi muscarinic receptor genes, tsA cells exp
ressed a cesium-sensitive inwardly rectifying potassium conductance th
at was reduced on application of the muscarinic receptor agonist carba
chol. This reduction was reversible on washout of carbachol and could
be completely inhibited by the muscarinic receptor antagonist atropine
. Conversely, stimulation of the m2 muscarinic receptor, when coexpres
sed with IRK1, resulted in no change in IRK1 current amplitude. Phorbo
l-12,13-dibutyrate, an activator of protein kinase C (PKC), mimicked t
he effect of m1 muscarinic receptor stimulation by inhibiting the IRK1
conductance. Preincubation with staurosporine or the specific PKC inh
ibitor calphostin C, before application of carbachol, fully prevented
the inhibition of IRK1 by m1 muscarinic receptor stimulation. Administ
ration of 8-bromo-cAMP, an activator of protein kinase A, and thapsiga
rgin, a stimulator of intracellular calcium release, had no effect on
IRK1, suggesting that these second messengers were not involved in the
mi muscarinic receptor-induced response. Therefore, the data indicate
that the m1 muscarinic receptor inhibits IRK1, presumably via stimula
tion of PKC. As IRK1 is widely distributed throughout the central nerv
ous system, it is possible that such an action on IRK1 underlies the i
nhibitory effects of muscarinic receptor stimulation on inwardly recti
fying potassium conductances observed in the brain.